Kommentar
A new rapamycin cream formulation improves facial angiofibromas
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad353 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Dermatology, 2023. Hauptthemen laut MEDLINE: Angiofibroma, Facial Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AngiofibromaFacial NeoplasmsHumansSirolimusAntibiotics, AntineoplasticAdministration, CutaneousEmollients
Substanzen
SirolimusAntibiotics, AntineoplasticEmollients
Zitieren
APA
(2023). A new rapamycin cream formulation improves facial angiofibromas. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad353
Vancouver
A new rapamycin cream formulation improves facial angiofibromas. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad353
BibTeX
@article{euvimed2023,
title = {A new rapamycin cream formulation improves facial angiofibromas},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad353}
}
EUVIMED